| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2901e694724c2a759f619944cb7d2a4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 |
| filingDate |
2000-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a5ff3f42ff8cae6a65e01ed0588daee |
| publicationDate |
2002-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-PA02002041-A |
| titleOfInvention |
USE OF DOCETAXEL FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA. |
| abstract |
The present invention is based on the discovery that docetaxel is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1 µM. Consequently, the use of docetaxe1, or a hydrate thereof, is provided in the manufacture of a medicament for use in the treatment of hepatocellular carcinoma. |
| priorityDate |
1999-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |